The SBIR Valley of Death — And How to Get Through It
Most SBIR-funded technologies never make it from Phase II to Phase III. The reasons are predictable. The way through is to line up the transition customer and the funding mechanism before Phase II ends.
The SBIR valley of death is the funding gap between Phase II R&D and Phase III commercialization. The way through is to line up your transition customer and your Phase III funding source before Phase II ends, not after.
The "valley of death" looks structural from the outside — a funding gap, a transition risk — and it is. But from the inside it's almost always a calendar problem first. A Phase II ends in June; the customer's FY26 O&M obligations close in September; nobody told the contracting officer until July. The bridge isn't more money. It's a customer who's been having the conversation for six months.
The phrase "valley of death" gets used in many contexts in defense innovation. In SBIR specifically, it has a precise meaning: the gap between the end of Phase II — when SBIR R&D funding stops — and the beginning of Phase III, when a real federal customer signs a contract for the resulting capability. Most companies do not survive that gap, not because the technology fails but because nobody set up the transition before the funding ran out.
Why the gap exists in the first place.
The SBIR program funds three things in sequence:
- Phase I — small feasibility studies.
- Phase II — full R&D and prototyping.
- Phase III — commercialization (no SBIR funding; non-SBIR contract dollars from any federal source).
Phase I and Phase II are funded out of the same SBIR set-aside pool. Phase III is not — it is funded out of customer-side appropriations. That funding gap is structural. The SBIR program intentionally does not fund commercialization; the assumption is that, if the technology is good, an operational customer will want to pay for it out of their own budget.
The catch: an operational customer does not magically appear at the end of Phase II. Someone has to find them, build the relationship, secure the budget, and prepare the contract file. The companies that do this during Phase II usually close Phase III on time. The companies that wait until Phase II ends usually do not close it at all.
The mistakes that put companies in the valley.
- Treating Phase II as a research engagement, not a customer-development engagement. The companies that close Phase III have usually spent the second half of Phase II in continuous conversation with a downstream customer.
- Assuming the funding program office will hand you a customer. Program offices that fund SBIR research are not usually the same people who operate the resulting capability. They typically can't make a Phase III award and don't have the budget for one even if they wanted to.
- Banking on a Phase II extension as the transition strategy. Phase II extensions buy time, not commercialization. They keep the lights on while the underlying problem — no Phase III customer, no Phase III funding — stays unsolved.
- Treating the DEC statement as something to write later. By the time you need a DEC, you are typically in budget-cycle pressure and the document gets rushed. A DEC drafted six months before it is needed is a meaningfully different document than one drafted under deadline.
The pattern that gets companies across.
The companies that cross the valley reliably do four things during Phase II, not after: identify the using customer early, help that customer find the funding, prepare the contract-file documentation in parallel with Phase II execution, and time the award to the customer's fiscal cycle. Each one is its own discipline — what specifically to say in the first customer conversation, how to read a budget submission, how to draft a DEC that holds up at higher-level review, when in the FY a contracting officer can still obligate without a CR risk. That's the work we do with clients. The pattern is consistent; the execution is where most attempts fail.
What to do if you are already in the valley.
If your Phase II has ended and there is no Phase III in sight, the path is still the same — identify the customer, secure the budget, prepare the contract file — but the timing pressure is higher and you have no concurrent R&D funding to keep the team intact while you do the work. Some companies bridge with internal R&D dollars, a Phase II extension, an SBIR-funded follow-on topic, or a strategic partnership. The honest answer is that the longer the gap runs, the harder it becomes to make a credible Phase III case, because the technology starts to look stale and the team starts to scatter. Start the transition work earlier next time, even if "next time" is a different SBIR topic with a different agency.
Stuck in the valley?
Free PDF: the work that turns a Phase II into a signed Phase III — what to start during Phase II, what to ask your contracting officer for, and what to avoid.
What is the SBIR valley of death?
The 'valley of death' is the gap between the end of Phase II R&D funding and the start of a Phase III commercial contract. Most SBIR-funded technologies never cross it because the awardee waits until Phase II ends to start the transition work.
How do you avoid the SBIR valley of death?
Line up your transition customer and your Phase III funding source before Phase II ends. Build the customer relationship, the DEC statement, and the contract-file documentation during Phase II — not after.
How long does the valley of death typically last?
For companies that start transition work after Phase II ends, the gap typically runs 12–24 months and many companies never close it. For companies that start during Phase II, it can be closed before Phase II's period of performance ends.
Whose problem is the valley of death?
It is the awardee's problem, structurally. The Phase II program office is not responsible for finding a Phase III customer. The using agency does not know you exist until you tell them. Nobody else owns the transition.
Have a Phase II that needs a Phase III path?
A 30-minute conversation. No pitch. We'll tell you what we'd do and whether we're the right fit.
Book a Call